NIH clinical trial tests a new vaccine for COVID-19 in humans. While still in early stages, the team hopes to make it available as soon as possible.
NIH clinical trial tests a new vaccine for COVID-19 in humans. While still in early stages, the team hopes to make it available as soon as possible.
Older individuals in low- and middle-income countries are considered to be the most vulnerable to COVID-19 but have yet to be properly acknowledged in global planning for the disease.
Doctors in Wuhan show that a chest CT is a more sensitive test for COVID 19 than the current standard.
Individual components of lipid nanoparticles are examined to understand how they interact with cells.
Kombucha fermentation generates a byproduct perfect for the creation of mechanically stable, biodegradable electronic components.
Young Innovator Awardee for 2025, Komor leads a group at UCSD developing precision genome editing methods using chemical biology.
High levels of a certain biomarker gives people a survival advantage, study finds.
SARS-CoV-2 marker used to trigger the immune system against cancer, showing promise in shrinking tumors and improving survival in mice.
Based on the same mRNA vaccine against COVID-19, a new prototype has shown potential to treat asthma, a condition with no known cure.
New findings shed light on how cervical cancer spreads to the lymph nodes, opening the door for treatments that could stop the process.